Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T-Reference-Cited by-同舟云学术

Early Response to Anti–Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes With Diabetic Macular Edema in Protocol T

Published:2018-11 Issue: Volume:195 Page:93-100
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Bressler Neil M.,Beaulieu Wesley T.,Maguire Maureen G.,Glassman Adam R.,Blinder Kevin J.,Bressler Susan B.,Gonzalez Victor H.,Jampol Lee M.,Melia Michele,Sun Jennifer K.,Wells John A.

Funder

National Eye Institute

National Institute of Diabetes and Digestive and Kidney Diseases

U.S. Department of Health and Human Services

Publisher

Elsevier BV

Subject

Ophthalmology

Reference16 articles.

1. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE;Nguyen;Ophthalmology,2012

2. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema;Wells;N Engl J Med,2015

3. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial;Wells;Ophthalmology,2016

4. Intravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studies;Brown;Ophthalmology,2015

5. Persistent macular thickening following intravitreous aflibercept, bevacizumab, or ranibizumab for central-involved diabetic macular edema with vision impairment: a secondary analysis of a randomized clinical trial;Bressler;JAMA Ophthalmol,2018

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the Nationwide Avastin Ban at a Tertiary Eye Care Hospital in Pakistan;Cureus;2024-07-23

2. Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment;Ophthalmology Science;2024-07

3. OCT Biomarkers and Visual Acuity in the Treatment of Diabetic Macular Edema;Ophthalmology Retina;2024-07

4. Long-term visual outcomes and fluid compartment changes in limited-early versus early response to anti-VEGF treatment for diabetic macular edema;Canadian Journal of Ophthalmology;2024-07

5. Switch to faricimab after initial treatment with aflibercept in eyes with diabetic macular edema;International Ophthalmology;2024-06-25